Relevant Contact Information

National Institutes of Health within the U.S. Department of Health and Human Services (DHHS)

National Institute on Drug Abuse (NIDA)

NIDA's mission is to lead the Nation in bringing the power of science to bear on drug abuse and addiction.  This charge has two critical components. The first is the strategic support and conduct of research across a broad range of disciplines. The second is ensuring the rapid and effective dissemination and use of the results of that research to significantly improve prevention, treatment, and policy as they relate to drug abuse and addiction. NIDA works with a variety of government and private-sector institutions to further scientific knowledge about drug abuse and addiction.

NIDA Press Office: 301-443-6245
E-mail: media@nida.nih.gov
Web: www.drugabuse.gov/news-events/contact-press-office

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIAAA is the primary National Institutes of Health (NIH) Institute conducting and supporting research on the causes, consequences, prevention, and treatment of alcohol abuse, alcoholism, and other alcohol-related problems. NIDA and NIAAA often collaborate on research and communications projects regarding the concurrent use of alcohol and other drugs; however, NIAAA is NIH's primary source for information on alcohol-related issues.

NIAAA Press Office: 301-443-3860
Web: www.niaaa.nih.gov

National Institute of Mental Health (NIMH)

NIMH is the primary NIH Institute conducting research on mental disorders. NIMH and NIDA often collaborate on research, as comorbidity is common (about 6 in 10 people with substance abuse problems also have co-occurring mental illnesses); however, NIMH is NIH's primary source for information on mental health research.

NIMH Press Office: 301-443-4536
E-mail: NIMHpress@mail.nih.gov
Web: www.nimh.nih.gov

Other Relevant Agencies Within DHHS

Substance Abuse and Mental Health Services Administration (SAMHSA)

SAMHSA conducts the National Survey on Drug Use and Health that is published every autumn. SAMHSA's Center for Substance Abuse Prevention provides national leadership in the development of substance abuse programs and services through prevention and treatment block grants. SAMHSA's Center for Substance Abuse Treatment provides a nationwide treatment facility locator (including a national toll-free referral number) and maintains a list of methadone treatment centers by State as well as information on physicians authorized to prescribe buprenorphine. SAMHSA and NIDA work closely together to integrate the latest on addiction science into community-based programs.

SAMHSA Press Office: 240-276-2130
Web: www.samhsa.gov

Food and Drug Administration (FDA)

FDA assures the safety and efficacy of medical drugs and produces education programs that advise consumers on how to take medicines safely. FDA and NIDA share information on scientific and communications programs related to safe medicines.

FDA Press Office: 301-827-6250
Web: www.fda.gov

Centers for Disease Control and Prevention (CDC)

CDC's Office on Smoking and Health works on a range of issues related to tobacco use, including promoting youth prevention and helping current smokers quit. In addition, CDC's National Center for Health Statistics is an excellent source for national health statistics, including data about substance abuse.

CDC Press Office: 202-395-6618
Web: www.cdc.gov/media and www.cdc.gov/tobacco

Relevant Offices Outside DHHS

Office of National Drug Control Policy (ONDCP)

ONDCP is a component of the Executive Office of the President. ONDCP shares information and collaborates with NIDA on a variety of addiction science issues; however, ONDCP is the chief office setting the policies, priorities, and objectives for the Nation's drug control program.

ONDCP Press Office: 202-395-6618
Web: www.whitehouse.gov/ondcp

Drug Enforcement Administration (DEA), within the U.S. Department of Justice

The DEA enforces the controlled substances laws and regulations of the United States. Although the DEA shares information with NIDA on drug supply issues, questions concerning investigations into drug trafficking, the diversion of pharmaceuticals, or drug-related criminal activity should be referred to the DEA press office.

DEA Press Office: 202-307-7977
Web: www.justice.gov/dea

Bureau of Justice Statistics (BJS)

BJS is an invaluable resource for data related to drug abuse and crime. BJS shares its data with NIDA as part of NIDA's ongoing initiative to provide effective drug treatment within the criminal justice system.

BJS Press Office: 202-514-2007
Web: bjs.ojp.usdoj.gov